$MEIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MEI Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MEI Pharma, Inc.. Get notifications about new insider transactions in MEI Pharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2021 | MEIP | MEI Pharma, Inc. | GHALIE RICHARD G | Chief Medical Offic ... | Option Exercise | A | 3.55 | 75,000 | 266,250 | 75,000 | |
Feb 24 2021 | MEIP | MEI Pharma, Inc. | DRISCOLL FREDERICK W | Director | Sell | S | 4.03 | 25,000 | 100,625 | 37,500 | 62.5 K to 37.5 K (-40.00 %) |
Jul 27 2020 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | M | 1.57 | 12,000 | 18,840 | 275,500 | |
Jul 27 2020 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Buy | M | 1.57 | 12,000 | 18,840 | 453,632 | 441.6 K to 453.6 K (+2.72 %) |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | DRISCOLL FREDERICK W | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | Urso David M | Chief Operating Off ... | Option Exercise | A | 3.49 | 525,000 | 1,832,250 | 525,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | Urso David M | Chief Operating Off ... | Grant | A | 0.00 | 50,000 | 0 | 74,106 | 24.1 K to 74.1 K (+207.42 %) |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 3.49 | 230,000 | 802,700 | 230,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | HOWSON TAMAR D | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 3.49 | 230,000 | 802,700 | 230,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | Clemens Kevan | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 3.49 | 680,000 | 2,373,200 | 680,000 | |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Grant | A | 0.00 | 80,000 | 0 | 441,632 | 361.6 K to 441.6 K (+22.12 %) |
Jul 07 2020 | MEIP | MEI Pharma, Inc. | Cohen Cheryl | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
Apr 14 2020 | MEIP | MEI Pharma, Inc. | Cohen Cheryl | Director | Option Exercise | A | 1.71 | 30,000 | 51,300 | 30,000 | |
Dec 20 2019 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Buy | P | 1.60 | 10,000 | 16,000 | 10,000 | 0 to 10 K |
Dec 20 2019 | MEIP | MEI Pharma, Inc. | DRISCOLL FREDERICK W | Director | Buy | P | 1.60 | 62,500 | 100,000 | 62,500 | 0 to 62.5 K |
Dec 20 2019 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Buy | P | 1.60 | 12,500 | 20,000 | 37,500 | 25 K to 37.5 K (+50.00 %) |
Dec 20 2019 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Buy | P | 1.60 | 18,750 | 30,000 | 361,632 | 342.9 K to 361.6 K (+5.47 %) |
Oct 01 2019 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | M | 1.57 | 20,000 | 31,400 | 287,500 | |
Oct 01 2019 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Buy | M | 1.57 | 20,000 | 31,400 | 342,882 | 322.9 K to 342.9 K (+6.19 %) |
Sep 09 2019 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Buy | P | 1.74 | 15,000 | 26,075 | 15,000 | 0 to 15 K |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | Urso David M | Chief Operating Off ... | Option Exercise | A | 2.52 | 350,000 | 882,000 | 350,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 2.52 | 230,000 | 579,600 | 230,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 2.52 | 680,000 | 1,713,600 | 680,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 2.52 | 230,000 | 579,600 | 230,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 2.52 | 40,000 | 100,800 | 40,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | A | 2.52 | 40,000 | 100,800 | 40,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Option Exercise | A | 2.52 | 40,000 | 100,800 | 40,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 2.52 | 40,000 | 100,800 | 40,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | DRISCOLL FREDERICK W | Director | Option Exercise | A | 2.52 | 40,000 | 100,800 | 40,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | Clemens Kevan | Director | Option Exercise | A | 2.52 | 40,000 | 100,800 | 40,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 2.52 | 40,000 | 100,800 | 40,000 | |
Jul 03 2019 | MEIP | MEI Pharma, Inc. | HOWSON TAMAR D | Director | Option Exercise | A | 2.52 | 60,000 | 151,200 | 60,000 | |
Aug 08 2018 | MEIP | MEI Pharma, Inc. | Urso David M | Chief Operating Off ... | Sell | S | 3.58 | 9,500 | 34,044 | 24,106 | 33.6 K to 24.1 K (-28.27 %) |
Aug 08 2018 | MEIP | MEI Pharma, Inc. | Urso David M | Chief Operating Off ... | Payment of Exercise | F | 3.75 | 17,764 | 66,615 | 33,606 | 51.4 K to 33.6 K (-34.58 %) |
Aug 08 2018 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Payment of Exercise | F | 3.75 | 17,709 | 66,409 | 33,661 | 51.4 K to 33.7 K (-34.47 %) |
Aug 08 2018 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Payment of Exercise | F | 3.75 | 54,093 | 202,849 | 319,727 | 373.8 K to 319.7 K (-14.47 %) |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | Urso David M | Chief Operating Off ... | Option Exercise | A | 4.28 | 220,000 | 941,600 | 220,000 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 4.28 | 130,000 | 556,400 | 130,000 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 4.28 | 300,000 | 1,284,000 | 300,000 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 4.28 | 100,000 | 428,000 | 100,000 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 4.28 | 40,000 | 171,200 | 40,000 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | A | 4.28 | 40,000 | 171,200 | 40,000 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Option Exercise | A | 4.28 | 40,000 | 171,200 | 40,000 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 4.28 | 40,000 | 171,200 | 40,000 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | DRISCOLL FREDERICK W | Director | Option Exercise | A | 4.28 | 40,000 | 171,200 | 40,000 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | Clemens Kevan | Director | Option Exercise | A | 4.28 | 40,000 | 171,200 | 40,000 | |
Jul 16 2018 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 4.28 | 40,000 | 171,200 | 40,000 | |
Jun 26 2018 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 4.33 | 130,000 | 562,900 | 130,000 | |
Jun 26 2018 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 4.33 | 380,000 | 1,645,400 | 380,000 | |
Jun 26 2018 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 4.33 | 100,000 | 433,000 | 100,000 | |
Jun 26 2018 | MEIP | MEI Pharma, Inc. | Urso David M | Sr. V.P. and Genera ... | Option Exercise | A | 4.33 | 130,000 | 562,900 | 130,000 | |
Mar 30 2018 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Payment of Exercise | F | 2.07 | 128,920 | 266,864 | 271,080 | 400 K to 271.1 K (-32.23 %) |
Feb 26 2018 | MEIP | MEI Pharma, Inc. | DRISCOLL FREDERICK W | Director | Option Exercise | A | 2.19 | 33,333 | 72,999 | 33,333 | |
Nov 29 2017 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 2.25 | 11,000 | 24,801 | 24,250 | 13.3 K to 24.3 K (+83.02 %) |
Nov 29 2017 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Sell | S | 2.21 | 11,000 | 24,272 | 13,250 | 24.3 K to 13.3 K (-45.36 %) |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 2.83 | 40,000 | 113,200 | 122,730 | |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | A | 2.83 | 40,000 | 113,200 | 122,730 | |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Option Exercise | A | 2.83 | 40,000 | 113,200 | 121,049 | |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 2.83 | 40,000 | 113,200 | 118,793 | |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | Clemens Kevan | Director | Option Exercise | A | 2.83 | 40,000 | 113,200 | 112,667 | |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 2.83 | 40,000 | 113,200 | 122,730 | |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | Urso David M | Sr. V.P. and Genera ... | Option Exercise | A | 2.83 | 130,000 | 367,900 | 537,500 | |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 2.83 | 135,000 | 382,050 | 555,556 | |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 2.83 | 380,000 | 1,075,400 | 1,234,166 | |
Jul 10 2017 | MEIP | MEI Pharma, Inc. | Drazba Brian G. | Chief Financial Off ... | Option Exercise | A | 2.83 | 50,000 | 141,500 | 200,000 | |
Aug 09 2016 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 0.00 | 102,740 | 0 | 102,740 | |
Aug 09 2016 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 0.00 | 102,740 | 0 | 102,740 | |
Aug 09 2016 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 51,370 | 0 | 51,370 | |
Aug 09 2016 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 51,370 | 0 | 51,370 | |
Aug 09 2016 | MEIP | MEI Pharma, Inc. | Urso David M | Sr. V.P. and Genera ... | Option Exercise | A | 0.00 | 51,370 | 0 | 51,370 | |
Aug 09 2016 | MEIP | MEI Pharma, Inc. | Urso David M | Sr. V.P. and Genera ... | Option Exercise | A | 0.00 | 51,370 | 0 | 51,370 | |
Aug 09 2016 | MEIP | MEI Pharma, Inc. | Zech Thomas M. | Chief Financial Off ... | Option Exercise | A | 0.00 | 17,123 | 0 | 17,123 | |
Aug 09 2016 | MEIP | MEI Pharma, Inc. | Zech Thomas M. | Chief Financial Off ... | Option Exercise | A | 0.00 | 17,123 | 0 | 17,123 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 1.36 | 40,000 | 54,400 | 86,924 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | Urso David M | Sr. V.P. and Genera ... | Option Exercise | A | 1.36 | 130,000 | 176,800 | 407,500 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | A | 1.36 | 40,000 | 54,400 | 86,924 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Option Exercise | A | 1.36 | 40,000 | 54,400 | 81,049 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 1.36 | 135,000 | 183,600 | 420,556 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 1.36 | 380,000 | 516,800 | 870,832 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 1.36 | 40,000 | 54,400 | 78,793 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | Clemens Kevan | Director | Option Exercise | A | 1.36 | 40,000 | 54,400 | 72,667 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | Cann Leah Rush | Director | Option Exercise | A | 1.36 | 40,000 | 54,400 | 86,924 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 1.36 | 40,000 | 54,400 | 86,924 | |
Aug 01 2016 | MEIP | MEI Pharma, Inc. | Zech Thomas M. | Chief Financial Off ... | Option Exercise | A | 1.36 | 110,000 | 149,600 | 338,757 | |
Nov 09 2015 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 1.75 | 157,352 | 275,366 | 3,163,105 | 3.3 M to 3.2 M (-4.74 %) |
Nov 09 2015 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 1.85 | 7,560 | 13,986 | 3,320,457 | 3.3 M to 3.3 M (-0.23 %) |
Nov 09 2015 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 1.91 | 225,660 | 431,011 | 3,328,017 | 3.6 M to 3.3 M (-6.35 %) |
Nov 09 2015 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 1.75 | 9,142 | 15,999 | 183,767 | 192.9 K to 183.8 K (-4.74 %) |
Nov 09 2015 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 1.85 | 440 | 814 | 192,909 | 193.3 K to 192.9 K (-0.23 %) |
Nov 09 2015 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 1.91 | 13,111 | 25,042 | 193,349 | 206.5 K to 193.3 K (-6.35 %) |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 1.57 | 20,000 | 31,400 | 46,924 | |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | Urso David M | Sr. V.P. and Genera ... | Option Exercise | A | 1.57 | 127,500 | 200,175 | 277,500 | |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | A | 1.57 | 20,000 | 31,400 | 46,924 | |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Option Exercise | A | 1.57 | 20,000 | 31,400 | 41,049 | |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 1.57 | 112,500 | 176,625 | 315,159 | |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 1.57 | 307,500 | 482,775 | 490,832 | |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 1.57 | 20,000 | 31,400 | 38,793 | |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | Clemens Kevan | Director | Option Exercise | A | 1.57 | 20,000 | 31,400 | 32,667 | |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | Cann Leah Rush | Director | Option Exercise | A | 1.57 | 20,000 | 31,400 | 46,924 | |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 1.57 | 20,000 | 31,400 | 46,924 | |
Jul 29 2015 | MEIP | MEI Pharma, Inc. | Zech Thomas M. | Chief Financial Off ... | Option Exercise | A | 1.57 | 90,000 | 141,300 | 228,757 | |
Mar 26 2015 | MEIP | MEI Pharma, Inc. | New Leaf Ventures II, L.P. | 10% Owner | Sell | S | 1.97 | 1,601,390 | 3,160,183 | 0 | 1.6 M to 0 (-100.00 %) |
Mar 26 2015 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | Option Exercise | O | 3.12 | 420,000 | 1,310,400 | 0 | ||
Mar 26 2015 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | Buy | O | 3.12 | 455,174 | 1,420,143 | 3,553,677 | 3.1 M to 3.6 M (+14.69 %) | |
Mar 26 2015 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | Option Exercise | O | 3.12 | 24,401 | 76,131 | 0 | ||
Mar 26 2015 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | Buy | O | 3.12 | 26,445 | 82,508 | 206,460 | 180 K to 206.5 K (+14.69 %) | |
Jan 23 2015 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 3.81 | 5,000 | 19,050 | 24,250 | 19.3 K to 24.3 K (+25.97 %) |
Jan 02 2015 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 4.26 | 1,500 | 6,390 | 5,350 | 3.9 K to 5.4 K (+38.96 %) |
Jan 02 2015 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 4.28 | 1,500 | 6,420 | 19,250 | 17.8 K to 19.3 K (+8.45 %) |
Dec 10 2014 | MEIP | MEI Pharma, Inc. | New Leaf Ventures II, L.P. | 10% Owner | Sell | S | 6.01 | 70,081 | 421,082 | 1,601,390 | 1.7 M to 1.6 M (-4.19 %) |
Dec 10 2014 | MEIP | MEI Pharma, Inc. | New Leaf Ventures II, L.P. | 10% Owner | Sell | S | 6.05 | 9,004 | 54,495 | 1,671,471 | 1.7 M to 1.7 M (-0.54 %) |
Dec 05 2014 | MEIP | MEI Pharma, Inc. | Clemens Kevan | Director | Option Exercise | A | 6.47 | 12,667 | 81,955 | 12,667 | |
Jul 16 2014 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 6.53 | 8,000 | 52,240 | 26,924 | |
Jul 16 2014 | MEIP | MEI Pharma, Inc. | Zech Thomas M. | Chief Financial Off ... | Option Exercise | A | 6.53 | 30,000 | 195,900 | 151,000 | |
Jul 16 2014 | MEIP | MEI Pharma, Inc. | Urso David M | Sr. V.P. and Genera ... | Option Exercise | A | 6.53 | 30,000 | 195,900 | 150,000 | |
Jul 16 2014 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 6.53 | 8,000 | 52,240 | 26,924 | |
Jul 16 2014 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 6.53 | 100,000 | 653,000 | 220,062 | |
Jul 16 2014 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 6.53 | 32,000 | 208,960 | 202,659 | |
Jul 16 2014 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | A | 6.53 | 8,000 | 52,240 | 26,924 | |
Jul 16 2014 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Option Exercise | A | 6.53 | 8,000 | 52,240 | 21,049 | |
Jul 16 2014 | MEIP | MEI Pharma, Inc. | Cann Leah Rush | Director | Option Exercise | A | 6.53 | 8,000 | 52,240 | 26,924 | |
Jul 16 2014 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 6.53 | 8,000 | 52,240 | 18,793 | |
Jul 02 2014 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 6.60 | 950 | 6,270 | 3,850 | 2.9 K to 3.9 K (+32.76 %) |
Jul 02 2014 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 6.52 | 1,050 | 6,846 | 17,750 | 16.7 K to 17.8 K (+6.29 %) |
Apr 08 2014 | MEIP | MEI Pharma, Inc. | Urso David M | Sr. V.P. and Genera ... | Option Exercise | A | 10.00 | 120,000 | 1,200,000 | 120,000 | |
Nov 25 2013 | MEIP | MEI Pharma, Inc. | New Leaf Ventures II, L.P. | 10% Owner | Sell | S | 8.25 | 365,000 | 3,011,250 | 1,680,475 | 2 M to 1.7 M (-17.84 %) |
Oct 29 2013 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 8.27 | 44 | 364 | 180,015 | 180.1 K to 180 K (-0.02 %) |
Oct 29 2013 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 8.30 | 2,263 | 18,790 | 180,059 | 182.3 K to 180.1 K (-1.24 %) |
Oct 29 2013 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 8.20 | 15,100 | 123,820 | 182,322 | 197.4 K to 182.3 K (-7.65 %) |
Oct 29 2013 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 8.27 | 756 | 6,252 | 3,098,503 | 3.1 M to 3.1 M (-0.02 %) |
Oct 29 2013 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 8.30 | 38,953 | 323,435 | 3,099,259 | 3.1 M to 3.1 M (-1.24 %) |
Oct 29 2013 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 8.20 | 259,900 | 2,131,180 | 3,138,212 | 3.4 M to 3.1 M (-7.65 %) |
Oct 03 2013 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 10.00 | 28,243 | 282,455 | 197,422 | 225.7 K to 197.4 K (-12.52 %) |
Oct 03 2013 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 11.00 | 5,551 | 61,046 | 225,665 | 231.2 K to 225.7 K (-2.40 %) |
Oct 03 2013 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 10.00 | 486,107 | 4,861,507 | 3,398,112 | 3.9 M to 3.4 M (-12.51 %) |
Oct 03 2013 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 11.00 | 95,539 | 1,050,671 | 3,884,219 | 4 M to 3.9 M (-2.40 %) |
Aug 20 2013 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 6.82 | 1,200 | 8,184 | 2,900 | 1.7 K to 2.9 K (+70.59 %) |
Aug 20 2013 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 6.82 | 1,400 | 9,548 | 16,700 | 15.3 K to 16.7 K (+9.15 %) |
Jul 17 2013 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Option Exercise | A | 7.43 | 6,730 | 50,004 | 13,049 | |
Jul 17 2013 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 7.43 | 34,000 | 252,620 | 170,659 | |
Jul 17 2013 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 7.43 | 6,730 | 50,004 | 18,924 | |
Jul 17 2013 | MEIP | MEI Pharma, Inc. | Zech Thomas M. | Chief Financial Off ... | Option Exercise | A | 7.43 | 10,000 | 74,300 | 121,000 | |
Jul 17 2013 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 7.43 | 6,730 | 50,004 | 18,924 | |
Jul 17 2013 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | A | 7.43 | 6,730 | 50,004 | 18,924 |